TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer — ASN Events
  1. Schedule
  2. Disease Informatics 2
  3. TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer

TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer (#84)

Hideaki Umeyama 1 , Mitsuo Iwadate 2 , Y-h. Taguchi 1
  1. Department of Physics, Chuo University, Tokyo, NON-U, Japan
  2. Department of Biological Science, Chuo University, Tokyo, Non-US/Canada, Japan

Background: Non-small cell lung cancer (NSCLC) remains lethal despite the development of numerous drug therapy technologies. About 85% to 90% of lung cancers are NSCLC and the 5-year survival rate is at best still below 50%. Thus, it is important to find drug target genes for NSCLC to develop an effective therapy for NSCLC.

Results: Integrated analysis of publically available gene expression and promoter methylation patterns of two highly aggressive NSCLC cell lines generated by in vivo selection was performed. We selected eleven critical genes that may mediate metastasis using recently proposed principal component analysis based unsupervised feature extraction [1-5]. The eleven selected genes were significantly related to cancer diagnosis. The tertiary protein structure of the selected genes were inferred by Full Automatic Modeling System, a profile based protein structure inference software, to determine protein functions and to specify genes that could be potential drug targets. 

Conclusions: We identified eleven potentially critical genes that may mediate NSCLC metastasis using bioinformatic analysis of publically available data sets. These genes are potential target genes for therapy of NSCLC. Among the eleven genes, TINAGL1 and B3GALNT1 are possible candidates for drug compounds that inhibit their gene expression. 

  1. Taguchi YH, Murakami Y. Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.PLoS One. 2013;8(6):e66714.
  2. Kinoshita R, Iwadate M, Umeyama H, Taguchi YH. Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets. BMC Syst Biol. 2014;8 Suppl 1:S4.
  3. Ishida S, Umeyama H, Iwadate M, Taguchi YH. Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery.Protein Pept Lett. 2014; 21(7) in press
  4. Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One. 2012;7(10):e48366.
  5. Taguchi YH, Okamoto A. Principal Component Analysis for Bacterial Proteomic Analysis, in "Pattern Recognition in Bioinformatics 2012", Lecture Notes in Computer Science, (2012) Vol. 7632, pp. 141-152